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The prevalence of HIV infection in India is likely toincrease dramatically in comingyears. Neuropsy-
chiatric and psychosocial problems are common among HIV infected individuals. Therapeutic 
measures employing biological, psychological and social approaches are necessary for managing these 
problems. Strategies for reducing high-risk behavioural patterns need to be developed for preventing 
the spread of infection. To cope with these tasks, neurology and psychiatric personnel should possess 
an adequate knowledge of the various aspects of HIV infection. Reports indicate a high prevalence of 
misconceptions among hospital staff. The paper provides a briefreview ofthe biological, neuropsychi-
atric, psychosocial and management aspects of HIV infection relevant to neurology and psychiatry. 
quired Immune Deficiency Syndrome 
(AIDS) has become a global problem, is caused 
by a retrovirus transmissible to normal human 
beings by sexual contact with infected homosex-
ual or by sharing of infected needles as usually 
happens in drug addicts and through transpla-
cental route from infected mother to foetus. 
Limited diagnostic facilities and long latency 
period between infection and disease manifes-
tation, the number of asymptomatic carriers 
and persons actually showing clinical symptom-
atology is gradually increasing and likely to in-
crease further in the coming years (Eisenberg, 
1989). 
HIV has a predeliction to affect the 
brain (Shaw et al, 1985) and 31-65% of patients 
with AIDS show neurological and neuropsychi-
atric manifestations (Janseen et al, 1980). The 
disease also carries considerable social stigma, 
and patients are ostracised and discriminated 
against, with a weakening of social supports 
(Faulstich, 1987). This, together with the lethal 
nature of the illness, causes significant neu-
ropsychological trauma to the affected individ-
uals (Cleary et al., 1988) as well as to their family 
and friends (Frierson et al, 1987). In addition, 
homosexuals and intravenous drug users, who 
constitute a part of the neuropsychiatric popu-
lation, account for 80-90% of reported AIDS 
cases (Small et al, 1983; Centres for Disease 
Control, 1985) at least in the western countries. 
In this setting, the role of neuropsychiatric per-
sonnel involves recognising and managing this 
problem among patients and their families, 
counselling regarding disease transmission, 
prognosis and coping techniques, and reducing 
high risk behavioual patterns among neuropsy-
chiatric sub-populations who are at risk for con-
tracting the infection. 
Misconceptions regarding the infection 
and resultant negative attitudes towards suffer-
ers have been found to be common among hos-
pital staff, showing reluctance to care for 
patients with AIDS (Fenton, 1987). This is fur-
ther complicated by controversies regarding 
risk of transmission of disease to health care 
staff (Anonymous, 1988), and the ethical as-
pects of compulsorily testing neuropsychotic 
patients for HIV infection (Jadresic, 1980; 
King, 1990). 
The current state of knowledge about 
HIV infection relevant to Neuropsychiatry is 
briefly reviewed in this article. 
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HIV: INFECTIVITYAND NATURAL 
HISTORY 
O nee a person is infected, he is infected 
for the rest of his life (Janssen et al., 1989). 
Following infection, the individual develops an-
tibodies within 3-6 months, or rarely longer 
(Forster & Pinching, 1988). While the antibod-
ies are useful for making a diagnosis by serolog-
ical tests like Enzyme linked immunosorbant 
assay (ELISA), Western blot and immuno flu-
orescence tests, they do not neutralise the virus 
and appear to offer no protection against dis-
ease. False negatives are sometimes seen due to 
the delay between infection and development of 
antibody response, needing further confirma-
tion and close observation with more tests at an 
interval of three months. The latency period 
between infection and disease manifestation is 
prolonged, varying from 1 month to 5 years, 
(Jaffe et al., 1985,1985a). or even longer. During 
this period, the individual is asymtomatic but 
capable of transmitting the infection to others 
(Fenton, 1987). Subsequently, some of those 
infected go on to develop the full clinical syn-
drome of AIDS. Others may manifest only some 
features of the syndrome, to be classified as 
having persistent generalised lymphadeno-
pathy (PGL) or AIDS-related complex (ARC). 
At present, the prognosis for those with PGL 
and ARC is uncertain. Most patients with clin-
ical AIDS experience rapid deterioration and 
death within 2-3 years, while a few with the best 
prognosis may survive upto 5 years (Volderd-
ing, 1985). 
The manifestations of the disease are 
explainable by the selectivity of HIV to prefer-
entially attack T4 lymphocytes and cells of the 
nervous system. Involvement of lymphocytes 
leads to immunosuppression, making the pa-
tient susceptible to opportunistic infections and 
neoplasms. Since the signs and symptoms de-
pend on the infecting agent and organ involved, 
they tend to be non-specific. Involvement of the 
nervous system results in 
neurological and neuropsychiatric manif-
estations, the nature of which again depends, on 
the region affected. Currently, management in-
volves treating the secondary infections and 
malignancies, along with general supportive 
measures. There is neither any drug to offer a 
specific cure, nor a vaccine to prevent the infec-
tion. Some clinical benefit has recently been 
reported with the use to anti-viral agents (Fischl 
et ai, 1987; Schmitt et al., 1988) but the benefits 
do not appear to be sustainable (Dournon ct al., 
1988). 
Despite low risk, the serious nature of 
the infection require that all personnel dealing 
with HIV positive patients take adequate pre-
cautions like wearing rubber gloves while deal-
ing with infected material, proper disposal of 
used needles and use of 10% sodium hypochlo-
rite for disinfection of blood spillage and work 
surfaces (Fenton, 1987). 
HOMOSEXUALITY AND HIV 
INFECTION 
JLn the U.S.A. more than 70% of patients 
suffering from AIDS are homosexuals. Centres 
for disease control (CDC) carried a nation wide 
study and compared 50 homosexual men having 
AIDS with 120 healthy homosexual men and 
came to conclusion that former had had a more 
number of male sex partners per year, started 
sex at an earlier age, and were having more risk 
to have syphilis and hepatitis than latter (Jaffe, 
et al., 1983). There has been another study 
where a comparison of 20 men with Kaposi's 
sarcoma with 40 homosexual controls was car-
ried out proving that the number of male sex 
partners in the year before diagnosis was defi-
nitely higher in AIDS patients (Marmar et al., 
1984). There has been 22% to 65% scropositiv-
ity for HIV virus in asymptomatic homosexual 
men in U.S.A. (C.D.C. 1984; Goedert et al., 
1984; Melbye et al., 1984; Weiss et ai, 1985). It 
will be quite interesting if somehow ultimate 
follow-up result of these patients are known. 116  L.C.THAKUR<?ra/. 
SUBSTANCE ABUSE ASPECT OF 
HIV INFECTION 
DS in homosexuals and a similar type of 
disorder was reported in I.V. drug abusers in 
New York city of U.S.A. simultaneously, which 
stimulated research workers to look for AIDS 
in I.V. drug abusers. They came to conclusion 
that it were heterosexual partnership in I.V. 
drug abusers which developed AIDS especially 
in female prostitutes who also formed majority 
among I.V. drug abuse there. These studies also 
confirmed that mode of transmission in such 
individuals was either through sexual inter-
course or by usage of infected needles used 
repeatedly by the partners (Harris et al, 1983; 
C.D.C., update 1985; Small et al, 1983; Selik et 
al, 1984). 
HIV RELATED NEUROPSYCHIAT-
RY MORBIDITY 
1^1 europsychiatric consultation rates for 
patients with HIV infection, being treated in 
general hospitals, range from 18.9% (Snoeral, 
1989) to 32.5% (Dilley et al, 1985). However 
these figures may not reflect the actual neuro-
psychiatric morbidity among HIV-infected 
population, as they depend upon the ability of 
the treating physician to recognise a neuropsy-
chiatric consultation. Among people with HIV 
infection, who have not been referred to Neu-
rologists or Psychiatrists, the prevalence of 
Neuropsychiatric disorders is reported to range 
from 31% (King, 1989) to 60% (Perry & Tross, 
1984), although the actual prevalence could be 
lower because of certain methodological flaws 
inherent in these studies (King, 1990). The 
range of neuro psychopathology encountered 
among HIV infected population is wide, rang-
ing from neurotic and adjustment disorders to 
major psychoses, AID complex dementia. 
Organic Neuropsychiatric disorders 
Among patients with clinical AIDS, showing 
involvement of the CNS, the most frequent 
complication is a progressive dementia which 
has been variously labelled as HlV-encepha-
lopathy, AIDS-Encephalopathy, sub-acute en-
cephalitis or AIDS- Dementia complex 
(Janssen et al, 1989). It may be seen in an overt 
form in about 1/3 of patients a', the time of AIDS 
diagnosis and in 2/3 of patients in the pre-termi-
nal stages (Price et al, 1988). The prevalence 
could be even higher if sub-clinical forms of the 
illness are included. It presents with a combina-
tion of cognitive, motor and behavioural dis-
trubances, with cognitive impairment 
predominating in most patients (Navia et al, 
1986). In the majority, the initial cognitive im-
pairment progresses to a picture of profound 
dementia, mutism, incontinence and coma 
(Fenton, 1987) and the mean survival time is 1.8 
months from the onset of severe dementia. 
The other common organic mental dis-
turbance is delirium, which may occur in a set-
ting of established dementia or be a 
consequence of opportunistic infections or 
CNS malignancies (Fenton, 1987). In addition, 
dementia accompanying AIDS may be punctu-
ated by episodes mimicking functional psycho-
ses such as schizophreniform, paranoid, 
depressive or hypomanic illnesses (Nurnbergef 
al, 1984; Gabel et al., 1986; Perry & Jacobsen, 
1986). But in most such instances, cognitive 
impairment suggestive of organic brain dys-
function is apparant. Where cognitive impair-
ment is minimal, differentiation between 
functional and organic psychoses is difficult 
(Snort a/., 1989). 
FUNCTIONAL PSYCHOSES 
ong HIV infected population, occur-
rence of functional psychoses unaccompanied 
by cognitive impairment is infrequent. Halstead 
et al (1988) reported 5 cases of functional psy-
choses without cognitive deficits, and reviewed 
2 other similar cases from literature. They failed NEUROPSYCHIATRY ASPECTS OF AIDS  117 
to find any common symptom pattern which 
could be considered specific for functional psy-
choses associated with HIV infection. Other 
reports indicate that DSM-III major depressive 
disorder is not uncommon among individuals 
with HIV infection (Dilley eta/., 1985; Sno et al., 
1989; Rabkin & Harrison, 1990), and patients 
with a past history of depressive episodes may 
be at increased risk for experiencing a recur-
rence (Dilley et al., 1985). 
NEUROTIC AND ADJUSTMENT 
DISORDERS 
l^leurotic and adjustment disorders ac-
count for the major portion of psychiatric mor-
bidity observed among HIV positive 
individuals. Adjustment disorders with dis-
turbed mood, depressive neurosis and anxiety 
neurosis were the commonest diagnoses among 
unselected HIV positive individuals consulta-
tion as well as among those referred for psychi-
atric consultation (Dilley et al., 1985; Sno et al., 
1989). Other conditions encountered include 
simple phobias, hypoactive sexual desire disor-
der (Rundell & Brown, 1990), panic disorder 
(Dilley et al., 1985) and obsessive-compulsive 
disorder (Green, 1986). In addition, a large 
number of individuals with a diagnosis of HIV 
infection have high levels of psychological dis-
tress (Cleary et al., 1988) which may, in part, be 
explainable as an expected reaction to a life 
threatening illness. Its similarity to psychologi-
cal reactions seen in other life threatening 
illnesses has been noted (Dilley et al., 1985; 
King, 1990). 
SUICIDAL RISK 
some investigators have noted the 
suicidal risk among AIDS patients to be strik-
ingly high (Frierson & Lippman, 1988; Marzuk 
et al., 1988), others have found such risk to be 
low (Chuang et al., 1988; Sno et al., 1989). 
Faulstich (1987) observed that suicidal ideation 
among AIDS patients is common, but actual 
attempts are not as frequent. This variability of 
findings may be explainable on the assumption 
that the risk of suicide varies at different stages 
of the illness, and with the social, physical and 
financial problems faced at each stage. Com-
pleted suicides among AIDS patients tend to be 
sudden and impulsive (Frierson & Lippman, 
1988; Marzuk et al., 1988), and are more com-
mon during the first six months after diagnosis, 
in association with cognitive dieline in the later 
stages, and among those who have witnessed the 
death of partners (Glass. 1988). 
FACTORS CONTRIBUTING TO 
NEUROPSYCHIATRY MORBID-
ITY 
In patients with AIDS, direct involvement 
of the CNS by the virus has been demonstrated 
(Shawef al., 1985) and even among asymptom-
atic HIV-positive individuals over 1/3 are re-
ported to show abnormal CSF findings 
(Appleman et al., 1988). Thus, the neurotropic 
nature of HIV accounts for many cases of or-
ganic psychiatric syndromes, while some could 
be caused by secondary infections, CNS malig-
nancies or the adverse effects of pharmacother-
apy. In case of functional psychoses without 
evidence of organic brain dysfunction, the posi-
tion is less clear. It is theoretically possible to 
hypothesise that functional psychoses can result 
if specific brain regions are involved by the 
virus, but supporting evidence to that effect is 
lacking. The association between functional 
psychoses and HIV infection, where present, is 
more likely to be coincidental than causal (Hal-
stead etal., 1988). 
Among HIV infected population mani-
festing neurotic and adjustment disorders, 118  L.C.THAKURera/. 
psychological and social factors seem to play an 
important role in the pathogenesis of psychiat-
ric morbidity, although the evidence for this is 
not entirely one sided. The three major issues 
forming the basis of psychological problems are 
terminality, isolation and money worries, which 
produce the signs and symptoms of anger, de-
nial, guilt and depression (Deuchar, 1984). The 
very knowlege of harbouring a potentially fatal 
infection of uncertain prognosis, with bleak 
treatment prospects and possible suffering and 
social isolation, can be sufficiently stressful to 
induce neuropsychiatric morbidity. Individuals 
who know that they are HIV positive are found 
to be at increased risk for psychological distress 
(Cleary et ai, 1988), and psychiatric problems 
more frequent among those who knew of their 
diagnosis for a shorter period and among those 
who have had past psychiatric problems (King, 
1989). There is also evidence and infected indi-
viduals who have not yet developed clinically 
AIDS show a higher prevalence of neuropsychi-
atric morbidity than those who have developed 
the syndrome (Atkinson et ai, 1988; Chuang et 
ai, 1989), possibly on account of prognostic 
uncertainties associated with the earlier 
stages (Chuang et ai, 1989). On the other hand, 
Perry et ai (1990) reported a lower prevalence 
of Neuropsychiatric disorders among those who 
already knew their diagnoses than among those 
who did not and Rundell & Brown (1990) found 
no difference in the frequency of Neuropsychi-
atric disorders with passage of time since the 
diagnosis was revealed to the patient. This con-
flicting data must however be weighed against 
evidence that major risk groups like homosexu-
als and drug users in general, tend to have a 
higher prevalence of psychopathology 
(Rounsaville et ai, 1982; Pillard, 1988) so that 
small sample sizes and differences in popula-
tions sampled can appreciably alter results 
across studies. 
The psychological trauma resulting 
from social consequences faced by an infected 
person has also been cited as an important fact-
or leading to Neuropsychiatric morbidity 
Faulstich, 1987; Ostrow et ai, 1987; Chuang et 
ai, 1989; King, 1990). The intense media cover-
age of AIDS has provided the public with infor-
mation that is not always accurate, resulting in 
misconceptions regardng health risks and in-
fectivity (Fenton, 1987). Infected individuals 
often face social, economic and occupational 
discrimination. A quarter of the patients who 
revealed their HIV status to others have been 
reported to suffer condemnation or rejection 
from social circles & society (King, 1989). 
Among high-risk groups, psychological distress 
was found to be more among those lacking so-
cial supports (Ostrow et ai, 1989). Whether 
social stressors alone can give rise to Neuropsy-
chiatric disorder is unclear, and at least one 
study (King, 1989) found no link between social 
rejection or condemnation and neuropsychiat-
ric disorder. On the whole, it appears that a 
multiplicity of factors including social, neu-
ropsychological economic and occupational 
stressors act in tandem to precipitate neuropsy-
chiatric morbidity. In a given individual, the 
personal meaning or subjective significance ac-
corded to each of these several factors could 
determine the psychological response. 
MANAGEMENT 
Symptoms of HIV infection, during early 
stages are vague and often may be similar to 
common ailments. Unexplained fever for more 
than 3 weeks, loss of weight (more than 10% of 
original weight) skin rash and diarrhoea (more 
than 2 weeks duration) need to be tested sero-
logically for AIDS. This entity should be sus-
pected and treated in all patients suffering from 
opportunistic infections like Tuberculosis, 
Toxoplasmosis, Pneuocysitis carinii, 
Cryptococcus meningitis, Candidiasis, 
Cytomegalo & Herpes viral infections and in 
malignancies like Kaposi's Sarcoma. In the ab-
sence of any vaccine aganist the disease antiviral 
drugs, antipsychotics, antidepressants and 
ECTs have all been used with some success in NEUROPSYCHIATRY ASPECTS OF AIDS  119 
treating neuropsychiatric disorders among pa-
tients with HIV infection (Fenton, 1987; 
Schaerf et al., 1989; Rabkin & Harrison, 1990). 
However some of the patients are particularly 
sensitive to drug side-effects (Fenton, 1987), 
and the use of anti-anxiety medications as the 
initial drug of choice may be preferable (Nich-
ols, 1983). 
Counselling, psychotherapy and cogni-
tive-behavioural techniques are all important 
aspects of management. In all patients suicidal 
risk should be carefully monitered and man-
aged. Deuchar (1984) advocates psychotherapy 
centered on restructuring and which involves 
finding a new meaning to life and adapting to 
the limitations of the illness. Supportive neuro 
psychotherapeutic approaches should involve 
issues such as guilt associated with sexual prac-
tices or drug abuse, possible social isolation, 
and acknowledgement of the illness and any 
associated fear or anger (Faulstich, 1987). Spe-
cific cognitive techniques may be useful in re-
ducing negative thinking and countering 
dysfunctional assumptions (Fenton, 1987). All 
attempts should be made to utilise and further 
fortify social supports, and to remove miscon-
ceptions regarding the illness among patient's 
family and friends. Counselling should aim at 
helping the patient and family to. understand 
current information about the disease, its prog-
nosis and modes of transmission (Fenton, 
1987). Careful advice should be given on pre-
ventive measures such as safe sex avoiding ex-
change of body fluids, not sharing razors and 
needles, and on how to clean up blood spills 
using hot water and household disinfectants. 
Hospital staff should avoid moral posturing and 
offer information to the patients in a secure, 
non-judgemental fashion (Dilley et al., 1985). 
The overall effort should be aimed at avoiding 
a defeatist attitude in the face of an incurable 
illness, land at improving the quality of patient's 
life. 
PSYCHOLOGICAL AND SOCIAL 
INTERVENTION 
descent and adult population need to 
be given information about the danger of AIDS 
epidemic, mode of spread, methods of preven-
tion and information regarding personal HTV 
antibody testing services. Efforts also should be 
made to change personal health beliefs and to 
change in the attitude of impulsive high risk 
behaviour related to drug abuse or other situa-
tional factors directed towards various sub-
groups who are going to have high incidence of 
HIV infection. It is the responsibility of the 
treating doctor, not only to treat the ailment but 
also to educate apart from the patient, people 
in and around him about methods to prevent the 
acquisition as well as mode of transmission of 
the disease. All persons who have AIDS related 
anxieties or neuropsychiatric syndrome should 
be given accurate medical information at a short 
notice without any hesitation by the medical 
profession. The AIDS virus does not spread 
through casual contact like shaking hands, 
touching and hugging. Neither does it spread 
through food, water, sneezing, coughing, in-
sects, toilets, swimming pools and sharing cups. 
EARLY IDENTIFICATION OF HIGH 
RISK PERSONS 
IVXany specific services and agencies help 
peole to alter patterns of social relationships 
and sexual behaviour to reduce the personal 
risk of getting HIV infection or its transmission. 
Such agencies also help people to cope with the 
fear and grief which commonly occur with death 
of an AIDS patient, in the community. 
The gay community has developed an 
AIDS related service organisation in the U.S.A. 
and has been successful in imparting informa-
tion, social and mental services to the people 
who suffer from AIDS. The AIDS related servi«» 120  L.C.THAKURrta/. 
ces there also provide substance abuse treat-
ment to the I.V. drug abusers who often are 
heterosexuals and educate them about safer sex 
(usage of separate disposable condom every 
time they have sex). 
Female prostitutes are known to have 
high rate of I.V. drug abuse (Small et al., 1983) 
and high seropositivity and cause of heterosex-
ual spread of H.I.V. infection. Community 
based education and information programmes 
will change the HIV transmission risk behavi-
our of female prostitutes. Obsteticians and Gy-
naecologists, have a sole moral responsibility to 
educate and counsel child bearing women re-
garding S.T.D. and HIV high sexual behaviour, 
HIV antibody testing and risk of HIV transmis-
sion with pregnancy. 
Type A hemophilics patients, their sex-
ual partners all will require information and 
psychosocial support services as they make up 
their mind for HIV testing and cope up with 
their anxieties and guilt about the actions that 
might have contributed to HIV infection in 
themselves and to the family members & 
friends. 
KNOWN HIV POSITIVE PERSONS 
ymptomatic persons need careful 
watch education and proper follow up at regu-
lar interval with HIV antibody testing services 
lest they indulge in spreading the disease to 
other people in the society. 
AIDS-RELATED-COMPLEX AND 
AIDS PATIENTS 
JVequire multidisciplinary team work ap-
proach, where a primary physician, neurologist, 
nurses, neuropsychologist psychiatrist and a so-
cial worker work in a co-ordinated manner to 
treat the above conditions and to communicate 
with the people who are involved in caring for 
such people in the community. 
ROLE OF FAMILY & FRIENDS 
X hey can provide emotional support ser-
vices to the sick patients with AIDS during his 
life time. They should be told that there is no 
need to fear and shun persons who are infected 
with the AIDS virus. They need a lot of Tender 
Loving Care (TLC) to help them live out their 
life with courage and dignity and share his fam-
ily responsibilities after his death. 
EMERGENCE OF AIDS IN INDIA 
-f\ larmed by the spread of HIV infection 
all over the world, it was Indian Councial of 
Medical Research in India, who took lead to 
establish AIDS Task Force in 1985. It strongly 
recommended setting up of Serosurveillance 
for persons belonging to high risk groups i.e. 
promiscuous heterosexual persons (prostitutes 
and their clients, patients having sexually trans-
mitted disease), intra venous drug users, per-
sons receiving blood and blood products, as 
usually happens during accidents, selective sur-
gical procedures, patients with blood disorders 
like hemophilia etc. The National Institute of 
Virology (NIV), Pune and the Christian Medi-
cal College, Vellore started screening in Octo-
ber, 1985. By April 1986, they had screened 3027 
persons of high risk groups and 10 prostitutes 
were found to be Seropositive and concluded 
that HIV infection has reached Indian shore. 
Subsequently, more and more patients with Se-
ropositivity started emerging among high risk 
groups from other places like Delhi, Kanpur, 
Chandigarh, Srinager, Lucknow, Manipur etc. 
and ICMR in collaboration with Directorate 
General of Health Services, Ministry of Health 
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lish more Sero-Surveillance centres and in 1987 
the National AIDS control Programme was 
fromulated with the objective to arrest the 
spread of infection among the promiscuous 
groups and for prevention of the disease by 
Information, Education and Communication to 
the high risk target population of the society. 
EPIDEMIOLOGICAL DATA AS ON 
31 ST AUGUST, 1991 
Blood sample screened 10,49,301 
Number of Seropositive cases 5732 
Seropositive Rate Per Thousand 5.4 
Aids cases in India 
Origin 
Indian 
Foreign 
Total 
Male 
49 
10 
59 
Female 
16 
03 
19 
Total 
65 
13 
78 
AIDS cases as detected in cities like Ma-
dras and Bombay appears more among hetero-
sexual promiscuous group prostitutes whereas 
in North eastern region prevalence of disease is 
more among I.V. drug users. 
STRATEGIES FOR REDUCING 
HIGH RISK BEHAVIOUR PAT-
TERN FOR PREVENTION OF 
SPREAD OF INFECTION. 
A. Government in collaboration with 
W.H.O. is trying to get more training facilities 
for its medical personnel in the advanced coun-
tries, so that on their return they train more 
manpower ready to look after the H.I.V. in-
fected patients in coming years with the latest 
methodology and advanced technology. It also 
proposes to set up AIDS Medical Care Units in 
different hospitals of the country especially in 
the metropolitan cities where incidence of the 
disease seems to be higher. So many workshops, 
seminars, symposiums are being organised by 
the National AIDS Control Programme Co-
ordinator to update and educate Medical and 
Para-medical personnel in general, so that they 
actively participate, in spreading knowledge 
about the disease, its transmission and preven-
tion among masses involved in community care 
services of the country. 
B. Central Health Education Bureau has 
taken a very active public education campaign 
through media like radio, television, pamphlets 
etc. to sensitise high risk target population by 
educating them about the importance of high 
moral values, use of safer sex and hazards of I.V. 
drug abuse in relation to spread of this dreadful 
disease. 
C. Setting up of more Surveillance Centres 
in the country for screening the high risk behavi-
our target population for HIV infection and 
check the trand of infection. 
D. Screening of all blood donors, blood 
receipients, blood and blood products in the 
Blood Banks for H.I.V. infection. It should also 
be done for patients attending S.T.D. clinics, 
antenatal clinics and all patients suspected to be 
suffering from opportunistic infections like tu-
berculosis, toxoplasmosis, candidiasis etc. (Lai, 
S, 1991). 
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